ascrinvacumab 0
bleselumab 0
brazikumab 0
brodalumab 0
dezamizumab 0
diridavumab 0
durvalumab 0
dusigitumab 0
elgemtumab 0
enfortumab_vedotin 0
farletuzumab 0
fibatuzumab 0
galcanezumab 0
gantenerumab 0
ifabotuzumab 0
ipilimumab 0
lorvotuzumab_mertansin 0
lumretuzumab 0
olaratumab 0
ontuxizumab 0
pamrevlumab 0
rinucumab 0
sarilumab 0
sifalimumab 0
suvizumab 0
tabalumab 0
tadocizumab 0
vedolizumab 0
veltuzumab 0
vesencumab 0
